Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sisi Li, Yongmin Tang, Jingying Zhang, Xiaoping Guo & Hongqiang Shen. (2011) 3A4, a new potential target for B and myeloid lineage leukemias. Journal of Drug Targeting 19:9, pages 797-804.
Read now
Read now
Wolfgang A. Bethge, D. Scott Wilbur & Brenda M. Sandmaier. (2006) Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation. Leukemia & Lymphoma 47:7, pages 1205-1214.
Read now
Read now
G Kobbe, R Fenk, F Neumann, A Bernhardt, U Steidl, M Kondakci, T Graef, M Aivado, M Vaupel, A-N Huenerlituerkoglu, R Kronenwett, H Pape, B Hildebrand, U Germing & R Haas. (2004) Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia. Cytotherapy 6:6, pages 533-542.
Read now
Read now
Articles from other publishers (51)
Gordon Winter, Carmen Hamp-Goldstein, Gabriel Fischer, Peter Kletting, Gerhard Glatting, Christoph Solbach, Hendrik Herrmann, Elisa Sala, Michaela Feuring, Hartmut Döhner, Ambros J. Beer, Donald Bunjes & Vikas Prasad. (2023) Optimization of Radiolabeling of a [90Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation. Cancers 15:14, pages 3660.
Crossref
Crossref
Jeffrey Y.C. Wong, An Liu, Chunhui Han, Savita Dandapani, Timothy Schultheiss, Joycelynne Palmer, Dongyun Yang, George Somlo, Amandeep Salhotra, Susanta Hui, Monzr M. Al Malki, Joseph Rosenthal & Anthony Stein. (2022) Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience review. Frontiers in Oncology 12.
Crossref
Crossref
Alexander R. Coltoff & Joseph G. Jurcic. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging
220
232
.
Martina Sollini, Francesco Bartoli, Sara Galimberti, Roberto Boni & Paola A. Erba. 2020. Nuclear Oncology. Nuclear Oncology
1
52
.
Martina Sollini, Francesco Bartoli, Sara Galimberti, Roberto Boni & Paola A. Erba. 2022. Nuclear Oncology. Nuclear Oncology
1329
1380
.
Mitchell A. Klenner, Tamim Darwish, Benjamin H. Fraser, Massimiliano Massi & Giancarlo Pascali. (2020) Labeled Rhenium Complexes: Radiofluorination, α-MSH Cyclization, and Deuterium Substitutions. Organometallics 39:13, pages 2334-2351.
Crossref
Crossref
Frederick Fasslrinner, Friedrich Stölzel, Michael Kramer, Raphael Teipel, Claudia Brogsitter, Anke Morgner, Claudia Arndt, Michael Bachmann, Mathias Hänel, Christoph Röllig, Jörg Kotzerke, Johannes Schetelig & Martin Bornhäuser. (2020) Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma. Biology of Blood and Marrow Transplantation 26:4, pages 691-697.
Crossref
Crossref
Nicolas Lepareur, Franck Lacœuille, Christelle Bouvry, François Hindré, Emmanuel Garcion, Michel Chérel, Nicolas Noiret, Etienne Garin & F. F. Russ KnappJr.Jr.. (2019) Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives. Frontiers in Medicine 6.
Crossref
Crossref
Esmee CM Kooijmans, Arend Bökenkamp, Nic S Tjahjadi, Jesse M Tettero, Eline van Dulmen-den Broeder, Helena JH van der Pal & Margreet A Veening. (2019) Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Database of Systematic Reviews 2019:3.
Crossref
Crossref
Sarah A. Buckley & John M. Pagel. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants
258
270
.
. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants
247
290
.
Jeffrey Y. C. Wong, Susanta Hui, Savita V. Dandapani & An Liu. 2017. Advances in Radiation Oncology. Advances in Radiation Oncology
155
189
.
Alaa M. Ali, Farrokh Dehdashti, John F. DiPersio & Amanda F. Cashen. (2016) Radioimmunotherapy-based conditioning for hematopoietic stem cell transplantation: Another step forward. Blood Reviews 30:5, pages 389-399.
Crossref
Crossref
Jun Fang, Ran Zhang, Huafang Wang, Mei Hong, Qiuling Wu, Dimin Nie, Yong You, Zhaodong Zhong, Weiming Li, Yu Hu & Linghui Xia. (2016) Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study. Leukemia Research 46, pages 61-68.
Crossref
Crossref
Joseph Gerard Jurcic, Jeffrey Y.C. Wong, Susan J. Knox, Daniel R. Wahl, Todd L. Rosenblat & Ruby F. Meredith. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology
399
418.e14
.
Sarah A. BuckleyRoland B. Walter. (2015) Antigen-specific immunotherapies for acute myeloid leukemia. Hematology 2015:1, pages 584-595.
Crossref
Crossref
Roland B. Walter, Oliver W. Press & Irwin D. Bernstein. 2015. Targeted Therapy of Acute Myeloid Leukemia. Targeted Therapy of Acute Myeloid Leukemia
531
555
.
Jane L. Liesveld, Philip Rubin & Louis S. Constine. 2014. ALERT • Adverse Late Effects of Cancer Treatment. ALERT • Adverse Late Effects of Cancer Treatment
623
655
.
Sebastiaan L Knijnenburg, Renée L Mulder, Antoinette YN Schouten-Van Meeteren, Arend Bökenkamp, Hester Blufpand, Eline van Dulmen-den Broeder, Margreet A Veening, Leontien CM Kremer & Monique WM Jaspers. (2013) Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Joseph G Jurcic. (2013) Radioimmunotherapy for hematopoietic cell transplantation. Immunotherapy 5:4, pages 383-394.
Crossref
Crossref
Inga Buchmann. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine
669
683
.
Ansgar S. SchulzGerhard GlattingManfred HoenigCatharina SchuetzSusanne A. GatzSimon GrewendorfMonika Sparber-SauerRainer MucheNorbert BlumsteinGabriele KropshoferMeinolf Suttorp, Donald Bunjes, Klaus-Michael DebatinSven N. ReskeWilhelm Friedrich. (2011) Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases. Blood 117:17, pages 4642-4650.
Crossref
Crossref
Karban Josef, Mocikova Heidi, Pytlik Robert, Klener Pavel & Trneny Marek. (2010) Expression of CD66 in non‐Hodgkin lymphomas and multiple myeloma. European Journal of Haematology 85:6, pages 496-501.
Crossref
Crossref
Norbert Grulke & Harald Bailer. (2009) Facing haematopoietic stem‐cell transplantation: do patients and their physicians agree regarding the prognosis?. Psycho-Oncology 19:10, pages 1035-1043.
Crossref
Crossref
Maria Corinna Palanca-Wessels & Oliver Press. 2010. Allogeneic Stem Cell Transplantation. Allogeneic Stem Cell Transplantation
733
746
.
Inga Buchmann, Ralf G. Meyer, Walter Mier & Uwe Haberkorn. (2009) Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity?. European Journal of Nuclear Medicine and Molecular Imaging 36:3, pages 484-498.
Crossref
Crossref
Suzanne Fanning & John W Sweetenham. 2009. Hematopoietic Stem Cell Transplantation in Clinical Practice. Hematopoietic Stem Cell Transplantation in Clinical Practice
267
277
.
Robert M. Sharkey & David M. Goldenberg. (2008) Use of antibodies and immunoconjugates for the therapy of more accessible cancers. Advanced Drug Delivery Reviews 60:12, pages 1407-1420.
Crossref
Crossref
Norbert Grulke, Donald Bunjes, Wolfgang Larbig, Horst Kächele & Harald Bailer. (2008) Physicians' prognostic estimates of survival for patients undergoing allogeneic hematopoietic stem cell transplantation. Journal of Psychosomatic Research 65:1, pages 61-66.
Crossref
Crossref
Sergio Amadori & Roberto Stasi. (2008) Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia. Current Opinion in Hematology 15:2, pages 95-100.
Crossref
Crossref
Richard Ratei, Leonid Karawajew, Richard Schabath, Angelika Ehrfeldt, Fritz Grunert & Wolf-Dieter Ludwig. (2008) Differential expression of the carcinoembryonic antigen-related cell adhesion molecules panCD66, CD66a, CD66c and of sialyl-Lewis x (CD15s) on blast cells of acute leukemias. International Journal of Hematology 87:2, pages 137-143.
Crossref
Crossref
Denise M. Oliansky, Frederick Appelbaum, Peter A. Cassileth, Armand Keating, Jamie Kerr, Yago Nieto, Susan Stewart, Richard M. Stone, Martin S. Tallman, Philip L. McCarthyJr.Jr. & Theresa Hahn. (2008) The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myelogenous Leukemia in Adults: An Evidence-Based Review. Biology of Blood and Marrow Transplantation 14:2, pages 137-180.
Crossref
Crossref
Steven I Park & Oliver W Press. (2007) Radioimmunotherapy for treatment of B-cell lymphomas and other hematologic malignancies. Current Opinion in Hematology 14:6, pages 632-638.
Crossref
Crossref
John E. Moulder & Eric P. Cohen. (2007) Future Strategies for Mitigation and Treatment of Chronic Radiation-Induced Normal Tissue Injury. Seminars in Radiation Oncology 17:2, pages 141-148.
Crossref
Crossref
Claudia Friesen, Gerhard Glatting, Bernd Koop, Klaus Schwarz, Alfred Morgenstern, Christos Apostolidis, Klaus-Michael Debatin & Sven N. Reske. (2007) Breaking Chemoresistance and Radioresistance with [213Bi]anti-CD45 Antibodies in Leukemia Cells. Cancer Research 67:5, pages 1950-1958.
Crossref
Crossref
M.E.C. Robbins & W. Zhao. 2007. Oxidative Stress and Neurodegenerative Disorders. Oxidative Stress and Neurodegenerative Disorders
135
164
.
Joseph G. Jurcic, Deborah A. Mulford & David A. Scheinberg. 2007. General Principles of Tumor Immunotherapy. General Principles of Tumor Immunotherapy
321
342
.
Jonathan E. Kolitz. 2006. Oncology. Oncology
1160
1181
.
J Kotzerke, D Bunjes & D A Scheinberg. (2005) Radioimmunoconjugates in acute leukemia treatment: the future is radiant. Bone Marrow Transplantation 36:12, pages 1021-1026.
Crossref
Crossref
Joseph G. Jurcic. (2005) Immunotherapy for acute myeloid leukemia. Current Oncology Reports 7:5, pages 339-346.
Crossref
Crossref
S. Kufner, R. Pelka Fleischer, T. Kroell, C. Schmid, H. Zitzelsberger, H. Salih, F. de Valle, W. Treder & H. M. Schmetzer. (2005) Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes. Cancer Immunology, Immunotherapy 54:10, pages 953-970.
Crossref
Crossref
Jaspreet Singh Jaggi, Surya V. Seshan, Michael R. McDevitt, Krista LaPerle, George Sgouros & David A. Scheinberg. (2005) Renal Tubulointerstitial Changes after Internal Irradiation with α-Particle–Emitting Actinium Daughters. Journal of the American Society of Nephrology 16:9, pages 2677-2689.
Crossref
Crossref
Wolfgang A. Bethge & Brenda M. Sandmaier. (2016) Targeted Cancer Therapy Using Radiolabeled Monoclonal Antibodies. Technology in Cancer Research & Treatment 4:4, pages 393-405.
Crossref
Crossref
Mark Ringhoffer, Norbert Blumstein, Bernd Neumaier, Gerhard Glatting, Stephanie Harsdorf, Inga Buchmann, Markus Wiesneth, Jorg Kotzerke, Thorsten Zenz, Andreas K. Buck, Peter Schauwecker, Stephan Stilgenbauer, Hartmut Dohner, Sven N. Reske & Donald Bunjes. (2005) 188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study. British Journal of Haematology 130:4, pages 604-613.
Crossref
Crossref
S. Kufner, H. Zitzelsberger, T. Kroell, R. Pelka-Fleischer, A. Salem, F. de Valle, C. Schmid, C. Schweiger, H. J. Kolb & H. M. Schmetzer. (2005) Leukaemia-Derived Dendritic Cells Can Be Generated From Blood or Bone Marrow Cells From Patients With Myelodysplasia: A Methodological Approach Under Serum-Free Culture Conditions. Scandinavian Journal of Immunology 62:1, pages 75-85.
Crossref
Crossref
S. Kufner, H. Zitzelsberger, T. Kroell, R. Pelka-Fleischer, A. Salem, F. de Valle, C. Schweiger, V. Nuessler, C. Schmid, H. J. Kolb & H. M. Schmetzer. (2005) Leukemia-Derived Dendritic Cells can be Generated from Blood or Bone Marrow Cells from Patients with Acute Myeloid Leukaemia: A Methodological Approach under Serum-Free Culture Conditions. Scandinavian Journal of Immunology 62:1, pages 86-98.
Crossref
Crossref
Frederick R Appelbaum. (2004) Immunobiologic therapies for myelodysplastic syndrome. Best Practice & Research Clinical Haematology 17:4, pages 653-661.
Crossref
Crossref
Mark Ringhoffer, Markus Wiesneth, Stephanie von Harsdorf, Richard F. Schlenk, Anita Schmitt, Peter P. Reinhardt, Margit Moessner, Wolfgang Grimminger, Thomas Mertens, Sven N. Reske, Hartmut Döhner & Donald Bunjes. (2004)
CD34
+
cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients
. British Journal of Haematology 126:4, pages 527-535.
Crossref
Crossref
Eric P Cohen & Mike E.C Robbins. (2003) Radiation nephropathy. Seminars in Nephrology 23:5, pages 486-499.
Crossref
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:1, pages 43-50.
Crossref
Crossref
P. J. Blower. (2003) 29 Inorganic pharmaceuticals. Annu. Rep. Prog. Chem., Sect. A: Inorg. Chem. 99, pages 589-614.
Crossref
Crossref